- Country or region
- China
- Trade topics
- Public procurement
- Context
- International Procurement Instrument investigations
Summary
- Registration name: IPI China medical devices
- Scope: Medical devices
- Third country concerned: China
- Initiation: 24/04/2024
The European Commission has decided on its own initiative to initiate, pursuant to Article 5(1) of Regulation (EU) 2022/1031, an investigation into alleged measures and practices of the People’s Republic of China (‘PRC) resulting in a serious and recurrent impairment of access of Union economic operators, goods and services to the PRC’s public procurement market for medical devices.
At the same time, the PRC is invited to enter into consultations with the European Commission in order to eliminate or remedy the alleged measures and practices.
Member States and interested parties are invited to participate in the investigation and provide relevant information, within 30 calendar days from the date of initiation of the investigation.
See the Notice of Initiation for further details.
Documents
- Notice of Initiation - 24 April 2024
- Letter to interested parties to submit information - 24 April 2024
- Press release - Commission launches first investigation under EU International Procurement Instrument - 24 April 2024